Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 29 | $3,864,221 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 31 Jul 2024 17:15 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 29 Jul 2024 | Sale | 4,066 | 15.58 | 63,348 | D |
| 31 Jul 2024 17:15 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 30 Jul 2024 | Sale | 934 | 15.55 | 14,524 | D |
| 12 Jul 2024 17:15 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 11 Jul 2024 | Sale | 5,000 | 12.26 | 61,300 | D |
| 02 Jul 2024 17:30 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 28 Jun 2024 | Sale | 20,000 | 10.77 | 215,400 | D |
| 04 Jun 2024 21:00 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 03 Jun 2024 | Sale | 5,000 | 10.93 | 54,650 | D |
| 04 Jun 2024 21:00 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 04 Jun 2024 | Sale | 5,000 | 12.33 | 61,650 | D |
| 04 Jun 2024 21:00 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 31 May 2024 | Sale | 15,000 | 9.41 | 141,150 | D |
| 07 May 2024 17:00 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 06 May 2024 | Sale | 5,000 | 10.92 | 54,600 | D |
| 02 May 2024 17:09 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 30 Apr 2024 | Sale | 15,000 | 9.51 | 142,650 | D |
| 29 Mar 2024 17:00 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 28 Mar 2024 | Sale | 20,000 | 10.97 | 219,400 | D |
| 04 Mar 2024 17:30 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 29 Feb 2024 | Sale | 100 | 13 | 1,300 | D |
| 04 Mar 2024 17:30 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 29 Feb 2024 | Sale | 24,900 | 12.41 | 309,009 | D |
| 02 Feb 2024 17:00 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 01 Feb 2024 | Sale | 5,000 | 15.56 | 77,800 | D |
| 02 Feb 2024 17:00 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 31 Jan 2024 | Sale | 25,000 | 12.23 | 305,750 | D |
| 02 Jan 2024 17:30 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 29 Dec 2023 | Sale | 2,500 | 14.1 | 35,250 | D |
| 02 Jan 2024 17:30 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 29 Dec 2023 | Sale | 22,500 | 13.3 | 299,250 | D |
| 01 Dec 2023 17:15 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 30 Nov 2023 | Sale | 25,000 | 12.57 | 314,250 | D |
| 22 Nov 2023 19:00 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 22 Nov 2023 | Sale | 3,989 | 13.9 | 55,447 | D |
| 22 Nov 2023 19:00 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 21 Nov 2023 | Sale | 4,192 | 14.86 | 62,293 | D |
| 02 Nov 2023 20:50 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 02 Nov 2023 | Sale | 5,000 | 15.64 | 78,200 | D |
| 02 Nov 2023 20:50 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 31 Oct 2023 | Sale | 25,000 | 12.05 | 301,250 | D |
| 03 Oct 2023 17:00 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 29 Sep 2023 | Sale | 25,000 | 12.41 | 310,250 | D |
| 05 Sep 2023 21:08 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 05 Sep 2023 | Sale | 10,000 | 11.62 | 116,200 | D |
| 05 Sep 2023 21:08 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 31 Aug 2023 | Sale | 15,000 | 9.36 | 140,400 | D |
| 05 Sep 2023 16:05 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 16 Aug 2023 | Sale A | 15,000 | 10.14 | 152,100 | D |
| 17 Aug 2023 17:00 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 16 Aug 2023 | Sale | 15,000 | 10.14 | 152,100 | D |
| 09 Jun 2023 17:30 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 08 Jun 2023 | Sale | 10,000 | 6.3 | 63,000 | D |
| 07 Jun 2023 21:30 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 06 Jun 2023 | Sale | 5,000 | 6.295 | 31,475 | D |
| 07 Jun 2023 21:30 | OLMA | Olema Pharmaceuticals Inc | HARMON CYRUS | Director | 05 Jun 2023 | Sale | 5,000 | 6.045 | 30,225 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)